Tag: RDN

Medtronic issues statement on the FDA Circulatory Systems Devices Advisory Panel vote for the Symplicity Spyral Renal Denervation System

DUBLIN, Aug. 23, 2023 /PRNewswire/ — Today, Medtronic announced the outcome of the U.S. Food & Drug Administration (FDA) Circulatory System Devices Panel (CSDP) meeting to review data presented in support of the Medtronic Symplicity Spyral™ Renal Denervation (RDN) System. The panel Committee voted unanimously (13-0) on safety and in favor (7-6) […]

Pythagoras Medical Receives CE-Mark for the ConfidenHT™ System

HERTSLIYA, Israel, March 26, 2018 /PRNewswire/ –Pythagoras Medical, a cutting edge medical device company established by Rainbow Medical, Israel’s premier medical device investment group, announced today that its ConfidenHT(TM) System has received a European CE Mark. ConfidenHT(TM) is a novel system for patients with resistant hypertension, which improves the efficacy […]